I am thrilled to welcome this diverse group of nephrologists who are performing at the top of their field to our North American Medical Advisory Board. The Medical Advisory Board’s experience and insights will be critical as we explore how to best leverage the proven benefits of SC+ to serve patients and providers in the United States dialysis market.